VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Total Return Calculator with Dividends Reinvested

Corbus Pharmaceuticals Holdings, Inc.

Popular:

The total return for Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock is +75.76% over the past 12 months. So far it's up 39.58% this year. The 5-year total return is -76.22%, meaning $10,000 invested in CRBP stock 5 years ago would be worth $2,378 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in CRBP 1 year ago, it would be worth $17,920 today — you'd have gained $7,920.

With Dividends Reinvested$17,920+79.20%

Price Only (No DRIP)$17,920+79.20%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in CRBP

1Y$17,576+$7,576 (+75.8%)75.8% CAGR

3Y$10,844+$844 (+8.4%)2.7% CAGR

5Y$2,378-$7,622 (-76.2%)-25.0% CAGR

10Y$1,620-$8,380 (-83.8%)-16.6% CAGR

15Y$1,221-$8,779 (-87.8%)-13.1% CAGR

20Y$1,221-$8,779 (-87.8%)-10.0% CAGR

30Y$1,221-$8,779 (-87.8%)-6.8% CAGR

Corbus Pharmaceuticals Holdings, Inc. did not pay dividends during this period. Total return = price return.

Loading CRBP total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+39.58%	—	+39.58%	—	$13,958
1Y	+75.76%	75.76%	+75.76%	—	$17,576
3Y	+8.44%	2.74%	+8.44%	—	$10,844
5Y	-76.22%	-24.97%	-76.22%	—	$2,378
10Y	-83.80%	-16.64%	-83.80%	—	$1,620
15Y	-87.79%	-13.08%	-87.79%	—	$1,221
20Y	-87.79%	-9.98%	-87.79%	—	$1,221
30Y	-87.79%	-6.77%	-87.79%	—	$1,221

Risk & Highlights

Best Year+424.84%2016

Worst Year-83.33%2022

Max Drawdown-61.83%2025-10-21 → 2026-02-05

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+8.89%	+8.89%	—	+0.41%	+8.5pp
2025	-32.39%	-32.39%	—	+16.64%	-49.0pp
2024	+86.41%	+86.41%	—	+24.00%	+62.4pp
2023	+70.62%	+70.62%	—	+24.81%	+45.8pp
2022	-83.33%	-83.33%	—	-19.95%	-63.4pp

CRBP outperformed the S&P 500 by 44.44pp over the past year (+75.76% vs +31.32%).

Loading summary...

CRBP Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
CRBPCorbus Pharmaceuticals Holdings, Inc.	$138M	+8.3%	+39.6%	+75.8%	—	+8.4%	-76.2%	-83.8%
AGIOAgios Pharmaceuticals, Inc.	$1.6B	-22.5%	-0.7%	-4.7%	—	+6.2%	-51.0%	-38.1%
RCUSArcus Biosciences, Inc.	$2.6B	+16.9%	+11.6%	+220.2%	—	+31.0%	-13.7%	+52.9%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
ARQTArcutis Biotherapeutics, Inc.	$3.0B	+2.2%	-16.7%	+68.8%	—	+69.5%	-25.9%	+10.9%
PRAXPraxis Precision Medicines, Inc.	$7.6B	+9.0%	+18.0%	+860.9%	—	+2005.6%	-18.4%	-19.0%
ABBVAbbVie Inc.	$362.6B	-0.8%	-9.1%	+13.1%	+3.6pp	+52.0%	+102.8%	+306.7%
REGNRegeneron Pharmaceuticals, Inc.	$74.9B	-5.5%	-7.0%	+29.7%	+0.6pp	-3.6%	+45.4%	+96.0%
INCYIncyte Corporation	$19.9B	+5.3%	-1.5%	+67.5%	—	+51.8%	+21.3%	+41.3%
ARDXArdelyx, Inc.	$1.7B	+18.9%	+15.4%	+79.7%	—	+69.5%	+327.7%	+290.1%
HALOHalozyme Therapeutics, Inc.	$7.8B	+5.2%	-5.6%	+11.7%	—	+119.1%	+39.1%	+598.4%

Compare:CRBP vs AGIO CRBP vs RCUS CRBP vs IMVT CRBP vs AGIO vs RCUS

About CRBP Dividend Returns

Corbus Pharmaceuticals Holdings, Inc. (CRBP) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CRBP over the past year?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) delivered a return of 75.76% over the past year. Since CRBP does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in CRBP be worth today?

A $10,000 investment in Corbus Pharmaceuticals Holdings, Inc. one year ago would be worth $17,576 today, representing a gain of $7,576.

Q3Does CRBP pay dividends?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CRBP, the total return equals the price-only return.

Q4Did CRBP beat the S&P 500?

Yes, Corbus Pharmaceuticals Holdings, Inc. (CRBP) outperformed the S&P 500 by 44.44 percentage points over the past year. CRBP delivered a total return of 75.76%, compared to the S&P 500's 31.32%. This 44.44pp alpha means investors in CRBP earned more than a passive S&P 500 index fund.

Q5What is CRBP's worst drawdown?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) experienced a maximum drawdown of -61.83% over the past year, declining from its peak on 2025-10-21 to its trough on 2026-02-05. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CRBP's long-term total return over 10, 20, or 30 years?

Here are Corbus Pharmaceuticals Holdings, Inc. (CRBP)'s long-term returns with dividends reinvested. Over 10 years, the total return is -83.8% (-16.6% CAGR) — $10,000 would have grown to $1,620. Over 20 years: -87.8% total return (-10.0% CAGR) — $10,000 → $1,221. Over 30 years: -87.8% total return (-6.8% CAGR) — $10,000 → $1,221. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CRBP's best and worst year?

Corbus Pharmaceuticals Holdings, Inc.'s best calendar year was 2016 with a total return of 424.8%. Its worst year was 2022 with a total return of -83.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 508.2 percentage points.